Table 5.
Analysis of prognostic factors in 512 patients with gastric cancer with an SRC component by multivariate analysis.
| B | SE | Sig | Exp(B) | 95% CI for Exp(B) | ||
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| T_COV_ | -0.003 | 0.006 | 0.652 | 0.997 | 0.986 | 1.009 |
| T_COV_1 | -0.008 | 0.006 | 0.167 | 0.992 | 0.981 | 1.003 |
| T-stage | 0.688 | 0.126 | <0.001 | 1.989 | 1.554 | 2.546 |
| N-stage | 0.413 | 0.075 | <0.001 | 1.512 | 1.305 | 1.751 |
| TNM stage | -0.241 | 0.269 | 0.370 | 0.786 | 0.464 | 1.331 |
| Tumor size | 0.134 | 0.163 | 0.410 | 1.143 | 0.831 | 1.573 |
| Age | 0.200 | 0.139 | 0.151 | 1.221 | 0.930 | 1.603 |
| Neutrophil | -0.221 | 0.176 | 0.209 | 0.802 | 0.568 | 1.132 |
| NLR | 0.000 | 0.186 | 0.999 | 1.000 | 0.695 | 1.438 |
| Hemoglobin | -0.001 | 0.151 | 0.996 | 0.999 | 0.744 | 1.342 |
| SII | 0.523 | 0.197 | 0.008 | 1.686 | 1.146 | 2.481 |
| PNI | 0.020 | 0.192 | 0.916 | 1.020 | 0.701 | 1.486 |
| Albumin | -0.128 | 0.188 | 0.498 | 0.880 | 0.609 | 1.273 |
| Total gastrectomy | -0.809 | 0.180 | <0.001 | 0.446 | 0.313 | 0.633 |
| Tumor location LMU | 0.436 | |||||
| Tumor location L | 0.431 | 0.352 | 0.222 | 1.538 | 0.771 | 3.068 |
| Tumor location M | 0.276 | 0.360 | 0.444 | 1.317 | 0.651 | 2.665 |
| Tumor location U | 0.650 | 0.384 | 0.091 | 1.915 | 0.901 | 4.068 |
| Tumor location LM | 0.136 | 0.361 | 0.707 | 1.145 | 0.565 | 2.323 |
| Tumor location MU | 0.384 | 0.561 | 0.494 | 1.468 | 0.489 | 4.405 |
SII: systemic immune-inflammation index; LM: lower and middle; MU: middle and upper; LMU: lower, middle, and upper; PNI: prognostic nutritional index; NLR: lymphocyte to neutrophil ratio; T_COV_: fibrinogen time-dependent variable; T_COV_1: prealbumin time-dependent variable.